HOME
Leading the way to a cure

PRESS RELEASES

Lupus Research Alliance Applauds House of Representatives for Passing the 21st Century Cures Act -- #CuresNow

December 1, 2016

The Lupus Research Alliance commends the U.S. House of Representatives for passing the bipartisan House Amendment last night 392-26, which updated the 21st Century Cures Act, intended to spur the development of new medical treatments in many disease areas including lupus.

Having worked hard over the past several years to voice the needs of the lupus community as this legislation took shape, the Lupus Research Alliance and our constituents are particularly pleased about this significant milestone. Our goal is to ensure that patients are involved in research that accelerates the discovery, development, and delivery of better, safer treatments and a cure for lupus.

We greatly appreciate that the bill, with the Amendment, addresses specific requests our lupus advocates voiced that will:

·     Strengthen and accelerate National Institutes of Health (NIH) biomedical research with a $4.8 billion investment

·     Incorporate patient feedback in researching and evaluating potential new treatments

·     Increase the numbers of clinical trials and streamline how they’re conducted

·     Shorten time for drug development

·     Include real-world evidence in FDA’s consideration of a new use for an approved drug

We thank the authors of this bill for their vision in spearheading and championing this critical legislation: Fred Upton (R-MI), Diana DeGette (D-CO), Frank Pallone, Jr. (D-NJ), Joe Pitts (R-PA) and Gene Green (D-TX).

The Lupus Research Alliance will continue to strongly advocate for the bill’s approval by the U.S. Senate.


Lupus Research Alliance Applauds House of Representatives for Passing the 21st Century Cures Act -- #CuresNow

December 1, 2016

The Lupus Research Alliance commends the U.S. House of Representatives for passing the bipartisan House Amendment last night 392-26, which updated the 21st Century Cures Act, intended to spur the development of new medical treatments in many disease areas including lupus.

Having worked hard over the past several years to voice the needs of the lupus community as this legislation took shape, the Lupus Research Alliance and our constituents are particularly pleased about this significant milestone. Our goal is to ensure that patients are involved in research that accelerates the discovery, development, and delivery of better, safer treatments and a cure for lupus.

We greatly appreciate that the bill, with the Amendment, addresses specific requests our lupus advocates voiced that will:

·     Strengthen and accelerate National Institutes of Health (NIH) biomedical research with a $4.8 billion investment

·     Incorporate patient feedback in researching and evaluating potential new treatments

·     Increase the numbers of clinical trials and streamline how they’re conducted

·     Shorten time for drug development

·     Include real-world evidence in FDA’s consideration of a new use for an approved drug

We thank the authors of this bill for their vision in spearheading and championing this critical legislation: Fred Upton (R-MI), Diana DeGette (D-CO), Frank Pallone, Jr. (D-NJ), Joe Pitts (R-PA) and Gene Green (D-TX).

The Lupus Research Alliance will continue to strongly advocate for the bill’s approval by the U.S. Senate.



1.5 million

people in the U.S. have Lupus.

172 million

dollars committed to lupus research by the Lupus Research Alliance.


We're walking across the United States to raise awareness and funds for lupus research.

 

Show your support by visiting the Lupus Research Alliance online store. Discover the perfect gift, or prepare for a walk with our selection of apparel and accessories.

Powered by Blackbaud
nonprofit software